---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-007348"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T15:13:32.017569+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Azenta Q2 revenue $159M (+7%); non-GAAP EPS $0.05; $111M goodwill impairment; guides FY rev lower

## Summary
- Revenue $159M, up 7% YoY; organic growth 7%; B Medical revenue up 51% to $23M.
- GAAP diluted EPS from continuing ops ($2.47) vs ($0.03); includes $111.3M non-cash goodwill impairment in B Medical.
- Non-GAAP diluted EPS $0.05 vs ($0.06); adjusted EBITDA $9M vs ($2M); margin 5.9% up 750 bps.
- FY2024 rev guidance lowered to $659-$671M (organic -1% to +1%); non-GAAP EPS raised to $0.27-$0.37.
- Repurchased 1.2M shares for $73.9M in Q2; $1.025B used of $1.5B authorization.

## SEC filing metadata
- accession: 0001558370-24-007348
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000155837024007348/0001558370-24-007348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000155837024007348/azta-20240508x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-007348
- JSON: https://secwatch.observer/filing/0001558370-24-007348.json
- Plain text: https://secwatch.observer/filing/0001558370-24-007348.txt

## Key facts
- Earnings Releases
  Azenta, Inc. reported the fiscal quarter ended March 31, 2024 results: revenue $159 million, net income $ (2.47) diluted EPS from continuing operations, EPS $ (2.47) diluted EPS from continuing operations. Guidance lowered.
  - Period: the fiscal quarter ended March 31, 2024
  - Revenue: $159 million
  - Net income: $ (2.47) diluted EPS from continuing operations
  - EPS: $ (2.47) diluted EPS from continuing operations
  - Guidance: lowered
  - Result: reported results
  source text: Day in March, we are confident in our position and the market opportunity which we are uniquely positioned to capture.” ​ Second Quarter Fiscal 2024 Results ● Revenue was $159 million, up 7% year over year. Organic revenue, which excludes the impacts from foreign exchange, was also up 7% year over year, with a nominal benefit from foreign exchange tailwinds.
  evidence_url: https://www.sec.gov/Archives/edgar/data/933974/000155837024007348/0001558370-24-007348-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.